Tag Archives: FDA

Kratom Advocates Sip Tea and Seethe at White House Rally Against DEA Ban


One user plans to move to Canada. Another plans to quit. Many more don’t know what to do.

By Steven Nelson | Staff Writer Sept. 13, 2016, at 6:20 p.m.

Several protest attendees brought their own bottle of kratom tea Tuesday to the White House. Those who did not were offered a Solo cup.

Several protest attendees brought their own bottle of kratom tea Tuesday to the White House. Those who did not were offered a Solo cup. Steven Nelson for USN&WR

Hundreds of passionate protesters gathered Tuesday near the White House to demand that the popular plant product kratom remain legal. It was jointly a business industry conference, a tea party and a desperate consumer lobbying effort — but the clear-eyed crowd appears to have little chance of near-term victory.

A comprehensive U.S. ban likely will take effect on Sept. 30, just a month after the Drug Enforcement Administration surprised users by saying it would invoke emergency powers to make leaves from the tree grown in Southeast Asia illegal by labeling two main constituents Schedule I substances.

In the face of long odds and silence from Capitol Hill, the event called by the American Kratom Association sought to pressure officials to reconsider while laying the groundwork for what may become a protracted re-legalization campaign.

A large jug of brewed kratom sat in the middle of Pennsylvania Avenue, with red Solo cups offered to anyone who wanted some. At least one reporter sipped the brew, which tasted like astringent green tea. Another journalist took a pill offered as a free sample by a businessman.

Kratom users who attended the rally said it’s wrong for them to lose legal access to what they say is an effective treatment for pain, addiction, depression and other conditions.

Though many said they were angry, chant-leaders asked the crowd of a couple hundred to stay on message and favored reason over rage, which often is a leading emotion at White House protests staged by marijuana reform advocates who say decades in Schedule I has stalled medical cannabis research amid millions of arrests.

“I’m usually very quiet but felt the need to come out and speak,” says Veronika Bamford-Conners, a kratom-selling store owner from Sullivan, Maine, where, she says, most of her customers are older than 55.

“If they don’t have insurance and can’t afford medications, they find a cheaper alternative in kratom,” she says, though some seem to prefer relief from the leaf to painkillers, such as a 73-year-old man who she says called her weeping “because pharmaceuticals were killing him” before.

Chants at the rally advertised the death toll from accidental overdoses of opioids – more than 28,000 in 2014 alone, including legal painkillers and illegal drugs like heroin – with the low or nonexistent U.S. toll from kratom.

The DEA says it believes 15 deaths were caused by kratom, though American Kratom Association founder Susan Ash says the group hired a toxicologist who concluded each case could be attributed to other drugs.

Many kratom users say the plant has helped them abstain from substances they formerly were addicted to, often heroin or prescription painkillers.

“Kratom saved me, I was a bad heroin addict,” says David Allen, who traveled from Chapel Hill, North Carolina. “It keeps cravings away and helped me not drink. I came because I don’t want to lose my medicine.”

Allen says that although the DEA – and even some former kratom users – say the drug can lead to dependence, it’s nothing like the grasp of opioids. He says he believe it’s about as abusable as coffee, which comes from a related plant, and that like coffee withdrawal, ending kratom can cause minor headaches.

Brad Miller, a physics teacher at Spotsylvania High School in Virginia, says he drinks small amounts of kratom tea between three and five times a day to treat arthritis in his knees. He says the effects are “very mild” and “just enough to take the edge off so I can get through my day standing.”

Miller says prescribed painkillers from his rheumatologist were too strong and that unlike opioids he hasn’t developed an addiction to kratom. He says he went on a weeklong camping trip and – unlike the experiences of some users – felt no withdrawal symptoms.

“I didn’t have withdrawal symptoms, but I did have arthritis pain,” he says. “I’d be surprised if anyone has experienced strong withdrawal symptoms.”

Though Miller and others at the event said they aren’t sure what they will do at the end of the month, Heather Hawkins says she’s made up her mind to move to Canada, where kratom remains legal.

Hawkins, a journalist with northern Florida’s Pensacola News-Journal and owner of the Kratom Literacy Project, says she has an incurable bladder disease and is eyeing Vancouver after already moved to the Sunshine State from Alabama in reaction to a local kratom ban.

Talk about moving abroad often is spouted unseriously by political partisans around election time, but Hawkins says she’s completely serious after living in a painkiller-induced haze that left her depressed and unable to get out of bed.

“I’m not going to stay here [if the ban takes effect] because I’m not going back to that life,” she says.

Hawkins says she’s in addiction recovery from cocaine, which she says she used as self-medication to give her the energy to power through her pain and despair, and that if she regarded kratom as a drug she would not take it.

Though kratom is widely known for claims that it can help keep opioid addicts clean, it’s also credited with sapping desire for other substances.

Jeremy Haley, owner of Colorado’s Rocky Mountain Kratom, says he began using kratom in 2012 after a drunk driving arrest, and that it has helped veer him away from his alcoholism, which runs in the family.

Although the ban hasn’t yet taken effect, Haley says local officials have shut down his shop for what he views as dubious reasons, making him unable to sell the remaining inventory – the latest in what he says has been a constant regulatory headache that featured him asking Yelp reviewers to delete positive reviews to placate federal officials who wanted proof he was not marketing kratom for human consumption.

Haley plans to open a totally legal apothecary shop if the ban takes effect.

CONTINUE READING…



RELATED CONTENT
Pot Breathalyzer Hits the Street

A futuristic drug-detecting fingerprint scanner may soon follow.

The DEA is looking for candidates to grow marijuana for research – but will it find any takers?


Wanted: Someone to grow marijuana for the federal government. Benefits: A contract likely worth millions and the chance to enable medical research. Requirements: Ability to deal with the costs and regulations that come with growing an illegal drug for the federal government.

For more than four decades, the University of Mississippi has had an exclusive license with the government to grow marijuana for federally sanctioned research. But this month, the Drug Enforcement Administration announced it would grant permission to other growers — an effort, it said, to expand the supply and variety of marijuana available for research.

So has the change set off a gold rush to grow the green? Not exactly.

STAT contacted almost a dozen agricultural schools, including those with industrial hemp programs, to gauge their eagerness to grow marijuana for the government.

Not interested, said Cornell University, the University of Kentucky, and Virginia Tech. Ditto, said Michigan State University, the University of Vermont, and Western Kentucky University.

No plans, said University of California, Davis, and University of Nebraska, Lincoln. Same with Colorado State University, Oregon State University, and Purdue University.

“We are very boring that way,” Janna Beckerman, a plant pathologist who researches hemp at Purdue, wrote in an email.

Some interested groups could be keeping their plans under wraps. And other possible candidates may be trying to get a better sense of what the DEA wants. But any reluctance might stem from more than being boring.

More on this…

To register with the agency, applicants will need to show that they will have security measures in place to protect the marijuana and be willing to comply with a host of other requirements. And depending on the scale of the operation, prospective growers will likely have to make significant investments to get it up and running.

Bob Morgan, an attorney at Much Shelist who formerly led the Illinois medical marijuana program, said that facilities in states that have strict regulations on medical marijuana growers are probably looking at multimillion-dollar expenditures for construction alone.

“I think everybody is just thinking about how to approach this,” said Dr. Igor Grant, director of the Center for Medicinal Cannabis Research at the University of California, San Diego. “What will it really take to get one of these DEA licenses?”

Grant said he would consider talking with other universities and agencies in California to see if it was worth the effort to get a cultivation operation in the state, but beyond that had not heard of groups intending to apply.

One researcher in the running is Lyle Craker, who studies medicinal plants at the University of Massachusetts, Amherst, and has tried in the past to get approval to grow marijuana. He did not reply to an email requesting comment, but a spokesman for a group called the Multidisciplinary Association for Psychedelic Studies — which sponsors related research — said it is supporting Craker’s efforts to get a license, as it has in the past.

Other possible applicants include independent growers who operate in states where medical and recreational marijuana is legal. Some cultivators have an expertise in running a large-scale marijuana facility — with state-of-the-art practices and security measures and experience dealing with state regulators — that in theory might appeal to federal authorities.

But the fact is, their existence contravenes federal law.

In a memo announcing the policy change, acting DEA Administrator Chuck Rosenberg said that it would consider whether applicants have “engaged in illegal activity involving controlled substances … regardless of whether such activity is permissible under state law.” While that doesn’t disqualify current cultivators, policy experts and people in the industry say the DEA won’t look highly upon them.

“They made it very clear that if you have been in violation of the [Controlled Substances Act], that would be weighted heavily against you,” said Rachel Gillette, an attorney at Greenspoon Marder in Colorado who represents marijuana businesses.

That might not stop people from trying, though.

Charlie Bachtell is the CEO and founder of Cresco Labs, which grows medical marijuana at three sites in Illinois. Bachtell said he is considering applying to the DEA because he wants to support research that could show marijuana has medical benefits.

“The future of this industry definitely starts with research,” Bachtell said. “The opportunity to help progress the acceptance, the elevation, and the professionalism of the medical cannabis industry really starts with research.”

The DEA’s policy change also opened the door to a new group of candidates: drug makers. While the Mississippi marijuana is funneled to academic research, Rosenberg wrote that marijuana can now be grown “for strictly commercial endeavors … aimed at drug product development.”

GW Pharmaceuticals, a company that is developing a drug for epilepsy from a component of marijuana called cannabidiol, said it has not made a decision about a growing facility in the United States, but remained vague enough to suggest possible interest. The company makes the drug, Epidiolex, in the United Kingdom, where it is based.

“We are exploring additional growing facilities in places around the world,” the company said in a statement.

The DEA’s application process is open, but the agency has set no deadline to select growers. The agency has indicated it wants just enough marijuana to be produced so research demands are met, but not more than that.

“It could be that two years from now, we still only have one registrant,” said Alex Kreit, an expert on marijuana law at Thomas Jefferson School of Law.

Even if cultivators gets licenses, they will confront a chicken-and-egg quandary: If they get special approval to grow marijuana, where do they get the supply they need to start it?

They could obtain marijuana from the University of Mississippi, but that would defeat the purpose of trying to expand the genetic variety of plants available. Or they could get seeds and plants from another country, such as Canada or Israel, with the proper permits.

An existing grower could also surrender some marijuana to law enforcement, which could then hand it over to a newly registered grower.

For its part, a spokesman wrote in an email that that the DEA “would require manufacturers to obtain their seeds from a lawful source, and the DEA would assist the new manufacturers in this regard.”

CONTINUE READING…

Marijuana studies

Craker is known for proposing that medical grade marijuana be available for scientific studies into its possible health benefits. Since the marijuana available for studies is too weak for any kind of medical study, he proposed that medical grade marijuanna be made available for research purposes. He has been named in many newspapers on this subject. The federal government refuses to give him a license to grow medical grade marijuana. On April 29, 2009, Senators Edward M. Kennedy and John F. Kerry wrote a letter to the Honorable David W. Ogden urging the Deputy Attorney General to delay a final decision on the application by Lyle E. Craker of the University of Massachusetts Amherst to produce research-grade marijuana for use in federally approved clinical trials[3][2][4][5]

FDA News Release: Kratom seized in California by US Marshals Service


Mitragyna_speciosa111

 

For Immediate Release

August 4, 2016

Release

The U.S. Food and Drug Administration announced today that the U.S. Marshals Service seized more than 100 cases of products labeled as containing kratom. The products are distributed by Nature Therapeutics LLC, which does business as Kratom Therapy and is located in Grover Beach, California. The seized products are marketed under the brand name Kratom Therapy, and are worth approximately $150,000.

The U.S. Department of Justice filed the complaint, on behalf of the FDA, in the U.S. District Court for the Central District of California, alleging that the seized kratom products are unapproved new drugs and misbranded drugs under the Federal Food, Drug, and Cosmetic Act.

“The FDA will continue to take aggressive enforcement action to safeguard the public from harmful drug products illegally marketed as treatments for which they have not been studied or approved,” said Melinda Plaisier, the FDA’s associate commissioner for regulatory affairs.

The FDA is warning consumers not to use any products labeled as containing the botanical substance kratom. Mitragyna speciosa, commonly known as kratom, grows naturally in Thailand, Malaysia, Indonesia and Papua New Guinea. Serious concerns exist regarding the toxicity of kratom in multiple organ systems. Consumption of kratom can lead to a number of health impacts including, respiratory depression, vomiting, nervousness, weight loss and constipation. Kratom has been indicated to have both narcotic and stimulant-like effects and withdrawal symptoms may include hostility, aggression, excessive tearing, aching of muscles and bones and jerky limb movements.

In January 2016, the FDA inspected the Grover Beach facility and also found that Nature Therapeutics’ website and social media sites included claims establishing that the company’s Kratom Therapy products are drugs because they are intended for use in the cure, mitigation, or treatment of various diseases. The FDA has not approved Nature Therapeutics’ products for any use. In addition, the complaint alleged that Nature Therapeutics’ products are also misbranded drugs because their labeling fails to provide adequate directions for use. The California Department of Public Health embargoed the products on behalf of the FDA.

In February 2014, the FDA issued an import alert regarding imported dietary supplements and bulk dietary ingredients that are, or contain, kratom without physical examination.

Health care professionals and consumers should report any adverse events related to products containing kratom to the FDA’s MedWatch Adverse Event Reporting program. To file a report, use the MedWatch Online Voluntary Reporting Form. The completed form can be submitted online or via fax to 1-800-FDA-0178.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

###

SOURCE

 

RELATED:

The DEA has filed notice of intent to add Kratom to schedule 1

The DEA has filed notice of intent to add Kratom to schedule 1


 

Mitragyna speciosa111.JPG

Various forms of kratom and teas made from the plant’s leaves are sold in cafes and on the internet. Their primary effect is to provide a short-lived peaceful and calm feeling that is described as pleasant. Consistent with this effect being opioid-like, anecdotal reports indicate that some users have used kratom to successfully recover from physical and psychological dependence on prescription opioids and heroin. Comments on my last report on kratom have also indicated the successful use of teas made from the plant in managing chronic pain without the side effects and addictive potential of prescription opioids like oxycodone, hydrocodone and morphine. LINK

Due to be published in the “Federal Register” on August 31st, 2016 is the DEA’s “Intent to reschedule” the opioids mitragynine and 7-hydroxymitragynine  These are the “ingredients” of the plant Kratom and they are placing it into schedule I using the “temporary scheduling provisions” of the Controlled Substances Act.

Federal Register Kratom

The Department of Justice, Drug Enforcement Administration, issued this document:

DOJ Kratom

There is a petition at Whitehouse.Gov that is asking the Federal Government to not go thru with this decision.

KRATOM PETITION

 

The “drug war” has taken enough of our plants and enough of our lives.  We cannot continue to let them regulate us out of every plant of food and medicine which were given to us as Our “inalienable rights” as Human Beings and laid out in Our Constitution as such, and regulate it out of our reach through the use of “Agenda 21” as laid out by the United Nations, in which the United States is one of only five “permanent members”!

First, PLEASE SIGN THE PETITION, and then make phone calls and write letters to your Representatives concerning this issue!

We hold these truths to be self-evident, that all men are created equal, that they are endowed by their Creator with certain unalienable Rights, that among these are Life, Liberty and the pursuit of Happiness.

RELATED STORIES:

“Rights and freedoms may in no case be exercised contrary to purposes and principles of the United Nations.” HOW THE UNITED NATIONS IS STEALING OUR “UNALIENABLE RIGHTS” TO GROW FOOD AND MEDICINE THROUGH THE U.N. CONVENTION ON NARCOTIC DRUGS AND AGENDA 21. Sheree Krider

The FDA Just Outlawed Hemp Oil – Secrets of the Fed.Com

FORBES announced today:  The DEA Is Placing Kratom And Mitragynine On Schedule I

Take Back Kentucky Legislative Action Alert

(KY) Oppose: Senate Bill 136: Banning of the Kratom Herb 2/22/2016

The FDA Just Outlawed Hemp Oil


The FDA Just Outlawed Hemp Oil — The #1 Cancer Treatment in The World

 

VIA/Hemp oil extracts containing CBDs (cannibidiols) are such a threat to the pharmaceutical industry that the FDA is now invoking totally insane justifications for outlawing them.

FDA’s own website: “12. Can products that contain cannabidiol be sold as dietary supplements? A. No. Based on available evidence, FDA has concluded that cannabidiol products are excluded from the dietary supplement definition…”

The FDA has also started sending aggressive warning letters to CBD product marketers.

Cannabis Oil - Banned by FDA

CBDs are non-psychoactive compounds found naturally in hemp plants. They work so well as powerful natural medicine that people everywhere are realizing CBDs work better than pharmaceuticals for treating epilepsy, seizures, neurological disorders and other serious health conditions (including HIV infections).

So the FDA has just launched a massive regulatory assault against CBDs by invoking the most insane logic you’ve ever heard. Here’s how it goes:

1) CBDs work so well that drug companies are now investigating them to be approved by the FDA as medicines.

2) Because CBDs are being investigated by drug companies, the FDA has granted CBDs status as being “investigated as a new drug.”

In the FDA’s own language from their website:

“FDA CONSIDERS A SUBSTANCE TO BE ‘AUTHORIZED FOR INVESTIGATION AS A NEW DRUG’ IF IT IS THE SUBJECT OF AN INVESTIGATIONAL NEW DRUG APPLICATION (IND) THAT HAS GONE INTO EFFECT.”

3) Because CBDs work so well and have been authorized for drug investigations, the FDA now OUTLAWS them being sold as dietary supplements.

Per the FDA’s own website:

“FDA HAS CONCLUDED THAT CANNABIDIOL PRODUCTS ARE EXCLUDED FROM THE DIETARY SUPPLEMENT DEFINITION UNDER SECTION 201(FF)(3)(B)(II) OF THE FD&C ACT.

“UNDER THAT PROVISION, IF A SUBSTANCE (SUCH AS CANNABIDIOL) HAS BEEN AUTHORIZED FOR INVESTIGATION AS A NEW DRUG FOR WHICH SUBSTANTIAL CLINICAL INVESTIGATIONS HAVE BEEN INSTITUTED AND FOR WHICH THE EXISTENCE OF SUCH INVESTIGATIONS HAS BEEN MADE PUBLIC, THEN PRODUCTS CONTAINING THAT SUBSTANCE ARE OUTSIDE THE DEFINITION OF A DIETARY SUPPLEMENT.”

4) Now the FDA has begun sending warning letters to CBD makers, claiming they are in violation of FDA regulations because they are selling “adulterated products.”

Adulterated with what, exactly? CBDs, of course!

“THE DEBATE OVER HEMP CBD’S LEGAL STATUS CONTINUES AFTER FDA SENT EIGHT WARNING LETTERS TO MANUFACTURERS OF CBD DIETARY SUPPLEMENT AND FOOD PRODUCTS EARLIER THIS MONTH,” REPORTS NUTRITIONAL OUTLOOK.

“THE WARNING LETTERS CITE IMPERMISSIBLE HEALTH CLAIMS USED TO MARKET THE PRODUCTS, AS WELL AS CBD’S INVALID STATUS AS A DIETARY INGREDIENT DUE TO ITS PRESENCE IN TWO DRUG APPLICATIONS CURRENTLY UNDER CONSIDERATION.”

The FDA just criminalized one of the most miraculous healing medicines in the world by handing it over to Big Pharma

In other words, the FDA just handed Big Pharma an absolute monopoly over CBDs (hemp oil extract) by ridiculously claiming such natural products are “adulterated” with molecules (CBDs) that the FDA says might one day become a drug.

“Drugs,” according to the FDA, are substances that are proven to treat, prevent or cure a disease, and thus the FDA’s own logic admits that CBDs must be able to treat, prevent or cure diseases, otherwise they would be useless as “drugs”.

But when a dietary supplement company makes the same claim, they are hit with aggressive warning letters from the FDA, threatening to shut them down, confiscate their products and seek criminal prosecution of the company executives.

This is how the FDA can instantly criminalize any vitamin or plant extract

Do you see how this twisted, corrupt regulatory tactic can allow the FDA to instantly criminalize any dietary supplement, vitamin, herb or plant extract?

Vitamin D, for example, could be outlawed by the FDA announcing that it has granted “Investigational New Drug application (IND)” status to any drug company studying vitamin D.

Using this same corrupt, mafia-style tactic, the FDA could outlaw resveratrol or even vitamin C, denying Americans the right to access safe, affordable, natural substances that are routinely found in nature.

It’s time to end the FDA’s monopolization over natural plant molecules

If humanity is ever to achieve medical freedom, we must end the FDA’s outrageous medical monopolization of plant molecules such as CBDs.

By allowing this corrupt, criminally-run regulatory agency to criminalize every molecule found in nature, our nation’s lawmakers condemn us all to life in what can only be called medical totalitarianism under FDA tyranny.

Any time a healing substances is found in nature, the FDA can simply assert that such molecules are now in the process of being studied as drugs and are therefore illegal to sell as dietary supplements even though they were developed by Mother Nature, not drug companies.

This FDA tactic is nothing more than the FDA proclaiming intellectual monopolies over all molecules of interest found in nature.

It is Monsanto-like in its arrogance and wickedness, and it deprives the People of their right to access medicinal plants and healing substances that have existed in nature for countless thousands of years long before the FDA ever came into existence (1906).

If we do not stop this FDA, we are all doomed to living under a totalitarian regulatory regime that will systematically criminalize every healing molecule found in nature, from the curcuminoids in turmeric root to green tea catechins and even phycocyanins found in spirulina.

That this federal agency has now resorted to such tactics of medical totalitarianism and outright tyranny is proof that we need to strip the FDA of regulatory powers over natural dietary supplements and limit its domain to pharmaceutical drugs only.

Coincidentally, a Presidential election is upon us that threatens to shake up the entire establishment if the right person wins.

“Establishment” candidates on both sides of the aisle would simply continue the FDA war on natural molecules that’s now under way, but there is one candidate who has openly threatened to challenge the authority of federal regulators like the EPA and FDA.

FDA begins crackdown by targeting inaccurate label claims… but it won’t end there

The FDA has now declared war on CBDs and hemp oil extracts. Its first targets are those companies who have inaccurate label claims or are committing outright fraud in claiming CBD concentrations that don’t even exist in their products.

On this point, I must agree that inaccurate label claims deserve regulatory enforcement. The CBD industry is heavily populated with fraudulent sellers whose products often contain no CBDs at all.

“THE FDA HAS TURNED ITS BACK ON THE CANNABIS INDUSTRY, CLAIMING THAT CBD PRODUCTS CANNOT BE SOLD AS DIETARY SUPPLEMENTS,” REPORTSCANNA BUSINESS.

“COMPANIES AFFECTED BY THE LATEST CRACKDOWN INCLUDE CALI STORES, DOSE OF NATURE, GREEN GARDEN GOLD, HEALTHY HEMP OIL, MICHIGAN HERBAL REMEDIES, MORGUE JUICE, PAIN BOMB AND SANA TE PREMIUM OILS. ACCORDING TO THE FDA’S ANALYSIS, ALL PRODUCTS CONTAINED DIFFERENT AMOUNTS OF 9-THC, THCA, CBDA, CBN AND CBD THAN THEY HAD CLAIMED.”

The second target of the FDA is companies that made disease treatment claims that their CBD products might treat epilepsy, cancer or other conditions.

The FDA, of course, routinely attacks any dietary supplement maker that tells the truth about the medicinal benefits of their products.

According to the FDA, there is no such thing as any food, nutrient, herb or natural molecule that has any ability whatsoever to treat, prevent or cure any disease.

This position is, of course, patently absurd and stands in total violation of nutritional science, but it is the “big lie” the FDA must maintain in order to keep putting dietary supplement companies out of business.

Once the FDA finishes destroying all the companies with inaccurate labels and disease marketing claims, it will target all the honest suppliers of CBDs who are selling genuine, honest products that contain accurate CBD labels.

This is the real goal of the FDA: to threaten, intimidate and destroy the entire CBD industry and thereby protect the medical monopolies of drug companies that can’t wait to cash in on these amazing molecules that really do treat disease (otherwise, Big Pharma would have no interest in them).

This is how the FDA keeps the medical racket marching along

And so the great medical monopoly racket marches on, with the FDA giving a big “F-YOU” to the American people while handing lucrative medical monopolies to its greed-driven friends in the pharmaceutical industry.

Meanwhile, the American people are denied healing medicine that works at a fraction of the cost of overpriced pharmaceuticals.

Entrepreneurial companies that offer such hemp oil extracts containing CBDs — natural medicines that could help reduce human suffering while lowering health care costs nationwide — are threatened by the FDA with devastating enforcement actions that could land their executives in prison.

This is all part of the FDA’s war on natural medicine that systematically criminalizes molecules found in nature and the people who seek to make those molecules available to patients in need.

While disease suffering skyrockets across America and medical expenses push more and more families over the threshold of bankruptcy and destitution, isn’t it comforting to know that your federal government is doing everything in its power to deny you access to safe, affordable natural medicine while protecting the profits of the drug giants?

What can you do to oppose this medical tyranny by the FDA?

None of this is ever going to change, by the way, if we keep electing establishment politicians to the White House.

If you want to see real change in the legalization of hemp extract components such as CBDs, you’d better vote for someone who terrifies the establishment and threatens to tear it down.

At the same time, you need to support health freedom organizations like the Alliance for Natural Health, which is fighting to keep dietary supplements legal in America.

You should also watch this video animation that exposes the anti-dietary supplement bias of PBS Frontline, which recently ran a totally dishonest hit piece documentary attacking supplements.

There is a nationwide effort under way right now to criminalize ALL dietary supplements and force every plant extract, vitamin or food concentrate to be regulated by the FDA as if they were prescription drugs.

This would utterly wipe out the entire dietary supplements industry and plunge America into an era of runaway disease, suffering and death as people are denying access to the healing nutrients that are presently preventing disease (and even reversing serious disease in some cases).

Finally, share this story and join the Natural News email list (below) to stay informed on all this.

As the editor of Natural News, I am fighting for your right to access CBDs and hemp oil extracts, as they are amazing natural medicines that can treat, prevent and in some cases even help cure serious health conditions.

The FDA is anti science and anti human rights

We have a fundamental human right to access healing plants found in nature, and the FDA has systematically sought to destroy that right and criminalize those who seek to express it.

Access to Mother Nature’s healing molecules is a fundamental human right that exists above and beyond the Bill of Rights. It is a DIVINE right.

To reestablish our access to these rights, we need a political revolution in Washington that puts people in power who are ready and willing to dismantle the FDA and end its devastating monopolies over dietary supplements, medicinal herbs and natural molecules found in nature.

We need to legalize health freedom in America and set this nation on a new path of disease prevention and drastically reduced health care costs through access to affordable, natural medicines.

The only way to accomplish this is to end the FDA’s reign of tyranny over the dietary supplements industry.

We need a new health freedom revolution in America, and it starts at the ballot box. It’s time to start electing outsiders, not insiders… people who the terrify the Washington establishment because they know their insidious grip on regulatory power will be challenged.

If you want medical marijuana legalized, or if you want access to CBD oil as an affordable dietary supplement, it’s time to start voting for people the establishment is desperately trying to destroy.

Because it is only those people who have any real hope of achieving the kind of political and legislative goals that will end the FDA’s stranglehold on natural medicine in America.

CONTINUE READING…

Is pot as dangerous as heroin? Feds’ decision on rescheduling marijuana coming soon


El Monte Police Lt. Christopher Williams looks over a portion of about 500 marijuana plants in various stages of growth after serving a search warrant at a home at 4300-block of Huddart Avenue in El Monte on Monday March 9, 2015.

 

By Brooke Edwards Staggs, The Orange County Register

Posted: 07/09/16, 8:37 PM PDT

 

At the same time Californians are preparing to vote on the legalization of adult marijuana use, the federal government is weighing whether pot should continue to be classified as a top-tier narcotic on par with heroin.

Within a month, the Drug Enforcement Administration is expected to release a much-anticipated decision that could alter cannabis’ ranking in the hierarchy of controlled substances — a formal listing that affects everything from medical research to taxing policy.

Since the list was created in 1970, marijuana has been ranked in Schedule I — the most restrictive category ­alongside heroin, LSD and peyote. The designation is reserved for drugs the DEA says have no proven medical use and are highly addictive.

What about Congress?

Even if the Drug Enforcement and Food And Drug administrations don’t recommend changing where marijuana falls on the controlled substances list, Congress could.

Elected officials are more likely to be influenced by growing public acceptance of marijuana — particularly if they represent one of 25 states with legal marijuana programs.

“I think that’s probably an easier sell than the decision coming from doctors and police,” said John Hudak, a deputy director with the Brookings Institution.

Some members of Congress support rescheduling marijuana, including Sen. Barbara Boxer. Some have even pitched descheduling it, including presidential hopeful Bernie Sanders. But none of those efforts gained traction, and Paul Armentano with the advocacy group NORML isn’t optimistic Congress will act on the issue anytime soon.

“I’m not aware of a single hearing much less a vote even in a subcommittee that has ever taken place at the Congressional level specific to the notion of reclassifying marijuana,” he said.

“We’re bound by the science,” said Melvin Patterson, spokesman for the DEA.

But many experts and advocates say the current classification is increasingly at odds with scientific studies on marijuana, which suggest the drug has medical value in treating chronic pain, seizures and a number of other conditions, with a lower addiction rate than alcohol.

The DEA ranking also lags behind a growing public consensus. Roughly 80 percent of Americans believe medical marijuana should be legal, according to recent polls, while some 60 percent support legalizing the drug for all adults.

“In 2016, this notion that cannabis possesses potential harms equal to that of heroin … simply doesn’t pass the smell test,” said Paul Armentano, deputy director of the National Organization for the Reform of Marijuana Laws, or NORML.

Medical marijuana is now legal in 25 states. Recreational use is allowed in four states plus Washington, D.C. If California green-lights recreational use this November, one in six Americans would live in a state where adults would be allowed to freely use cannabis.

The question of how cannabis should be ranked has been hotly debated since Congress placed it in the Schedule I group when it passed the Controlled Substances Act nearly 46 years ago. The drug’s classification has been reviewed periodically, with the latest reexamination prompted by a petition filed with the DEA five years ago by the then-governors of Rhode Island and Washington.

In April, the DEA advised Congress that it expected to announce a decision in the first half of 2016.

Patterson said officials now “clearly anticipate something happening in the next month.”

The agency has several options: keep cannabis as a Schedule I drug; reclassify some or all of its compounds to a lower schedule; or remove the plant from the controlled substances list altogether.

There is a greater chance than ever that marijuana will be rescheduled, said John Hudak, who studies the topic as a deputy director with the Brookings Institution. But he still expects pot to remain a Schedule I drug.

Advertisement

“It needs to cross a threshold that says it has an accepted medical value,” Hudak said. “While there are plenty of patients and doctors who do believe it has medical value, that’s not a universal belief in the medical community.”

Leslie Bocskor, president of Las Vegas-based cannabis advisory firm Electrum Partners, thinks the odds slightly favor a reclassification of marijuana to Schedule II. That category includes morphine and cocaine, which the DEA says are highly addictive but have some medical value. A form of cocaine, for example, is used by some dentists as a local anesthetic.

The least restrictive of the five schedule categories, Schedule V, includes cough syrup with a bit of codeine.

Alcohol and tobacco aren’t included on the DEA’s controlled substances list, even though federal studies have found both are associated with higher dependency rates than marijuana.

Patterson said the DEA frequently hears from people frustrated that marijuana hasn’t been rescheduled sooner.

“They have their mind made up on what marijuana does in the short term,” he said. “But what about different strains? What about 10 years from now or even 20 years from now? Long-term effects matter.”

For the medical marijuana community, even reclassifying cannabis as a Schedule II drug would offer some vindication.

“At a minimum, it would bring an end to the federal government’s longstanding intellectual dishonesty that marijuana ‘lacks accepted medical use,’ ” Armentano said.

Such a shift by the DEA also might offer a small boost to at least half-a-dozen states with medical or recreational marijuana initiatives on the ballot this November.

That potential to give some credence to legalization efforts is one of the reasons a few members of Congress, including Sen. Chuck Grassley of Iowa, and the organization Smart Approaches to Marijuana, or SAM, cite in arguing against reclassifying marijuana.

“Rescheduling would simply be a symbolic victory for advocates who want to legalize marijuana,” SAM wrote in a policy paper on the issue.

But both the California and American medical associations say rescheduling pot could lower the barriers a bit for federally sanctioned drug research.

The DEA has never turned down a marijuana research request that met federal criteria, Patterson said. But experts say red tape related to Schedule I drug research is so formidable that it discourages applications. So while there are tens of thousands of peer-reviewed studies on marijuana, there are few costly and rigorous double-blind, placebo-controlled trials involving cannabis.

Moreover, researchers say, marijuana studies are saddled with restrictions that don’t apply to other Schedule I drugs.

Since 1968, for example, the federal government has said only a tightly controlled stock of high-quality marijuana grown under contract by the University of Mississippi can be used for FDA-approved studies. Armentano said that restricts the supply available for research.

If marijuana were reclassified to at least Schedule III — alongside Tylenol with codeine and anabolic steroids — it would mean the nation’s rapidly growing number of cannabis-related businesses could begin deducting operating expenses from their federal taxes.

Under a tax rule imposed during the Reagan Administration’s 1980s anti-drug war, businesses dealing in Schedule I or II substances are prohibited from writing off common expenses such as rent, utilities or advertising.

Harborside Health Center, a large Oakland dispensary, has been battling the IRS over the rule for five years, after being assessed $2.4 million for illegal deductions. A decision in that case is expected soon.

Even if cannabis was moved down the controlled substances list to the least-restrictive category, the industry would still be likely to face business and regulatory hurdles.

Armentano likened such a change, should it come, to the first stride in a marathon.

“Technically, it gets you closer to the finish line,” he said. “But you still have a whole hell of a long way to go.”

Pot would remain an illegal substance under federal law. Reclassification wouldn’t necessarily open access to banking services, Hudak said. And doctors wouldn’t automatically switch to writing prescriptions, as opposed to “recommendations,” for medical marijuana, since that’s only allowed for FDA-approved drugs.

“There are certain people who play up rescheduling as an earth-shattering reform,” Hudak said. “It is not.”

He said sweeping changes would only come in the unlikely event that cannabis was completely descheduled, putting it on par with alcohol.

That would allow local governments to create cannabis policies free from federal interference, Armentano said, the way they can set their own hours for when bars stop serving alcohol or make entire counties “dry.”

Armentano isn’t optimistic the DEA will move marijuana to a less restrictive category, but he said there’s been one positive result from the current review.

“There’s attention being paid to how they handle this situation in a way that just wasn’t there before,” he said. “If the DEA goes down the same path as it has in the past, I think they’re going to have some explaining to do.”

CONTINUE READING…

Gary Johnson predicts Obama will reclassify marijuana on way out of office


Gary Johnson, who ran for the White house in 2012 as the Libertarian Party candidate, now leads a national movement to allow third-party candidates in national presidential debates. (Associated Press) ** FILE **

 

By David Sherfinski – The Washington Times – Tuesday, March 29, 2016

Former New Mexico Gov. and 2016 Libertarian White House hopeful Gary Johnson says he thinks President Obama is going to remove marijuana from the government’s “Schedule I” list of narcotics considered particularly harmful and addictive on his way out of office.

“It’s going to be just like alcohol,” Mr. Johnson told The Washington Times Tuesday. “I’m going to predict that Obama, when he leaves office, is going to deschedule marijuana as a Class I narcotic. I wish he would have done that to this point, but I think he’s going to do that going out the door. That’s a positive.”

 

Marijuana is currently on the Schedule I list alongside drugs like LSD and heroin. The Drug Enforcement Agency defines Class I drugs as having a high potential for abuse and no currently accepted medical use.

Democratic presidential front-runner Hillary Clinton, among others, has suggested reclassifying the drug under Schedule or Class II. Those drugs include cocaine, but also certain painkillers like oxycodone that are available with a medical prescription.

Mr. Johnson’s campaign followed up by saying that the former governor would prefer that the president remove marijuana from the controlled substances list entirely, allowing states to legalize and regulate as they and their voters choose.

But the campaign said most discussion and a more likely near-term step has centered around reclassifying it to Schedule II, which would remove a barrier to prescribed medical uses, though they said that either move would be a step in the right direction.

Mr. Obama has said that Congress can move on such a reclassification.

“What is and isn’t a Schedule I narcotic is a job for Congress,” Mr. Obama said in a 2014 interview with CNN. “It’s not something by ourselves that we start changing … no, there are laws undergirding those determinations.”

Tom Angell, chairman of the advocacy group Marijuana Majority, said the attorney general and the secretary of Health and Human Services can move to get rescheduling done without further legislation under the Controlled Substances Act.

“It’s tough to predict what the president will do on this issue before he leaves office, but if he’s willing to uphold his pledge to set policy based on science, and he listens to the majority of Americans who support marijuana reform, he will exercise his administrative authority for rescheduling,” Mr. Angell said.

Mr. Johnson pointed out that there are still some “dry counties” in the country with respect to alcohol and predicted marijuana would eventually be in that same category.

“I think every municipality has to realize that all the planes to Denver every single weekend are filled up, and that they’re missing out, and Colorado is absolutely vibrant,” he said. “Is it due to marijuana? I think it’s a contributing factor.”

“I don’t know how long it’s been since you’ve been to Colorado, but I think you can sense vibrancy, and it’s there,” he said.

CONTINUE READING…

This is how the FDA can instantly criminalize any vitamin or plant extract


HEALTH FREEDOM ALERT: The FDA just outlawed CBDs and hemp oil extracts by claiming all plant molecules now belong exclusively to Big Pharma

Sunday, March 20, 2016
by Mike Adams, the Health Ranger
Tags: CBD, hemp oil extract, FDA regulations

CBD

(NaturalNews) Hemp oil extracts containing CBDs (cannibidiols) are such a threat to the pharmaceutical industry that the FDA is now invoking totally insane justifications for outlawing them.
CBDs are non-psychoactive compounds found naturally in hemp plants. They work so well as powerful natural medicine that people everywhere are realizing CBDs work better than pharmaceuticals for treating epilepsy, seizures, neurological disorders and other serious health conditions (including HIV infections).
So the FDA has just launched a massive regulatory assault against CBDs by invoking the most insane logic you’ve ever heard. Here’s how it goes:
1) CBDs work so well that drug companies are now investigating them to be approved by the FDA as medicines.
2) Because CBDs are being investigated by drug companies, the FDA has granted CBDs status as being “investigated as a new drug.” In the FDA’s own language from their website, “FDA considers a substance to be ‘authorized for investigation as a new drug’ if it is the subject of an Investigational New Drug application (IND) that has gone into effect.”
3) Because CBDs work so well and have been authorized for drug investigations, the FDA now OUTLAWS them being sold as dietary supplements. Per the FDA’s own website: “FDA has concluded that cannabidiol products are excluded from the dietary supplement definition under section 201(ff)(3)(B)(ii) of the FD&C Act. Under that provision, if a substance (such as cannabidiol) has been authorized for investigation as a new drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, then products containing that substance are outside the definition of a dietary supplement.”
4) Now the FDA has begun sending warning letters to CBD makers, claiming they are in violation of FDA regulations because they are selling “adulterated products.” Adulterated with what, exactly? CBDs, of course! “The debate over hemp CBD’s legal status continues after FDA sent eight warning letters to manufacturers of CBD dietary supplement and food products earlier this month,” reports Nutritional Outlook. “The warning letters cite impermissible health claims used to market the products, as well as CBD’s invalid status as a dietary ingredient due to its presence in two drug applications currently under consideration.”

The FDA just criminalized one of the most miraculous healing medicines in the world by handing it over to Big Pharma

In other words, the FDA just handed Big Pharma an absolute monopoly over CBDs (hemp oil extract) by ridiculously claiming such natural products are “adulterated” with molecules (CBDs) that the FDA says might one day become a drug.
“Drugs,” according to the FDA, are substances that are proven to treat, prevent or cure a disease, and thus the FDA’s own logic admits that CBDs must be able to treat, prevent or cure diseases, otherwise they would be useless as “drugs”.
But when a dietary supplement company makes the same claim, they are hit with aggressive warning letters from the FDA, threatening to shut them down, confiscate their products and seek criminal prosecution of the company executives.

This is how the FDA can instantly criminalize any vitamin or plant extract

Do you see how this twisted, corrupt regulatory tactic can allow the FDA to instantly criminalize any dietary supplement, vitamin, herb or plant extract?
Vitamin D, for example, could be outlawed by the FDA announcing that it has granted “Investigational New Drug application (IND)” status to any drug company studying vitamin D.
Using this same corrupt, mafia-style tactic, the FDA could outlaw resveratrol or even vitamin C, denying Americans the right to access safe, affordable, natural substances that are routinely found in nature.

It’s time to end the FDA’s monopolization over natural plant molecules

If humanity is ever to achieve medical freedom, we must end the FDA’s outrageous medical monopolization of plant molecules such as CBDs. By allowing this corrupt, criminally-run regulatory agency to criminalize every molecule found in nature, our nation’s lawmakers condemn us all to life in what can only be called medical totalitarianism under FDA tyranny.
Any time a healing substances is found in nature, the FDA can simply assert that such molecules are now in the process of being studied as drugs and are therefore illegal to sell as dietary supplements even though they were developed by Mother Nature, not drug companies.
This FDA tactic is nothing more than the FDA proclaiming intellectual monopolies over all molecules of interest found in nature. It is Monsanto-like in its arrogance and wickedness, and it deprives the People of their right to access medicinal plants and healing substances that have existed in nature for countless thousands of years long before the FDA ever came into existence (1906).
If we do not stop this FDA, we are all doomed to living under a totalitarian regulatory regime that will systematically criminalize every healing molecule found in nature, from the curcuminoids in turmeric root to green tea catechins and even phycocyanins found in spirulina.
That this federal agency has now resorted to such tactics of medical totalitarianism and outright tyranny is proof that we need to strip the FDA of regulatory powers over natural dietary supplements and limit its domain to pharmaceutical drugs only.
Coincidentally, a Presidential election is upon us that threatens to shake up the entire establishment if the right person wins. “Establishment” candidates on both sides of the aisle would simply continue the FDA war on natural molecules that’s now under way, but there is one candidate who has openly threatened to challenge the authority of federal regulators like the EPA and FDA.

FDA begins crackdown by targeting inaccurate label claims… but it won’t end there

The FDA has now declared war on CBDs and hemp oil extracts. Its first targets are those companies who have inaccurate label claims or are committing outright fraud in claiming CBD concentrations that don’t even exist in their products.
On this point, I must agree that inaccurate label claims deserve regulatory enforcement. The CBD industry is heavily populated with fraudulent sellers whose products often contain no CBDs at all.
“The FDA has turned its back on the cannabis industry, claiming that CBD products cannot be sold as dietary supplements,” reports Canna Business. “Companies affected by the latest crackdown include Cali Stores, Dose of Nature, Green Garden Gold, Healthy Hemp Oil, Michigan Herbal Remedies, Morgue Juice, Pain Bomb and Sana Te Premium Oils. According to the FDA’s analysis, all products contained different amounts of 9-THC, THCa, CBDa, CBN and CBD than they had claimed.”
The second target of the FDA is companies that made disease treatment claims that their CBD products might treat epilepsy, cancer or other conditions. The FDA, of course, routinely attacks any dietary supplement maker that tells the truth about the medicinal benefits of their products. According to the FDA, there is no such thing as any food, nutrient, herb or natural molecule that has any ability whatsoever to treat, prevent or cure any disease. This position is, of course, patently absurd and stands in total violation of nutritional science, but it is the “big lie” the FDA must maintain in order to keep putting dietary supplement companies out of business.
Once the FDA finishes destroying all the companies with inaccurate labels and disease marketing claims, it will target all the honest suppliers of CBDs who are selling genuine, honest products that contain accurate CBD labels. This is the real goal of the FDA: to threaten, intimidate and destroy the entire CBD industry and thereby protect the medical monopolies of drug companies that can’t wait to cash in on these amazing molecules that really do treat disease (otherwise, Big Pharma would have no interest in them).

This is how the FDA keeps the medical racket marching along

And so the great medical monopoly racket marches on, with the FDA giving a big “F-YOU” to the American people while handing lucrative medical monopolies to its greed-driven friends in the pharmaceutical industry. Meanwhile, the American people are denied healing medicine that works at a fraction of the cost of overpriced pharmaceuticals.
Entrepreneurial companies that offer such hemp oil extracts containing CBDs — natural medicines that could help reduce human suffering while lowering health care costs nationwide — are threatened by the FDA with devastating enforcement actions that could land their executives in prison.
This is all part of the FDA’s war on natural medicine that systematically criminalizes molecules found in nature and the people who seek to make those molecules available to patients in need. While disease suffering skyrockets across America and medical expenses push more and more families over the threshold of bankruptcy and destitution, isn’t it comforting to know that your federal government is doing everything in its power to deny you access to safe, affordable natural medicine while protecting the profits of the drug giants?

What can you do to oppose this medical tyranny by the FDA?

None of this is ever going to change, by the way, if we keep electing establishment politicians to the White House. If you want to see real change in the legalization of hemp extract components such as CBDs, you’d better vote for someone who terrifies the establishment and threatens to tear it down.
At the same time, you need to support health freedom organizations like the Alliance for Natural Health, which is fighting to keep dietary supplements legal in America.
You should also watch this video animation that exposes the anti-dietary supplement bias of PBS Frontline, which recently ran a totally dishonest hit piece documentary attacking supplements.
There is a nationwide effort under way right now to criminalize ALL dietary supplements and force every plant extract, vitamin or food concentrate to be regulated by the FDA as if they were prescription drugs. This would utterly wipe out the entire dietary supplements industry and plunge America into an era of runaway disease, suffering and death as people are denying access to the healing nutrients that are presently preventing disease (and even reversing serious disease in some cases).
Finally, share this story and join the Natural News email list (below) to stay informed on all this. As the editor of Natural News, I am fighting for your right to access CBDs and hemp oil extracts, as they are amazing natural medicines that can treat, prevent and in some cases even help cure serious health conditions.

The FDA is anti science and anti human rights

We have a fundamental human right to access healing plants found in nature, and the FDA has systematically sought to destroy that right and criminalize those who seek to express it. Access to Mother Nature’s healing molecules is a fundamental human right that exists above and beyond the Bill of Rights. It is a DIVINE right.
To reestablish our access to these rights, we need a political revolution in Washington that puts people in power who are ready and willing to dismantle the FDA and end its devastating monopolies over dietary supplements, medicinal herbs and natural molecules found in nature.
We need to legalize health freedom in America and set this nation on a new path of disease prevention and drastically reduced health care costs through access to affordable, natural medicines. The only way to accomplish this is to end the FDA’s reign of tyranny over the dietary supplements industry.
We need a new health freedom revolution in America, and it starts at the ballot box. It’s time to start electing outsiders, not insiders… people who the terrify the Washington establishment because they know their insidious grip on regulatory power will be challenged. If you want medical marijuana legalized, or if you want access to CBD oil as an affordable dietary supplement, it’s time to start voting for people the establishment is desperately trying to destroy. Because it is only those people who have any real hope of achieving the kind of political and legislative goals that will end the FDA’s stranglehold on natural medicine in America.

Food Forensics: Breakthrough book from the Health Ranger exposes shocking scientific truth about what you’re really eating

Over two years in the making, Food Forensics publishes the heavy metals testing results from over 800 foods, supplements, spices and superfoods. Available now for pre-order on Amazon and BN, click here for the Food Forensics website and book preorder links. “An amazing job on so many levels and an absolute must read.” – Michael T. Murray… “Mike Adams new book, Food Forensics, should be required reading for all the Big Food, Big Biotech apologists who continue to poison and mislead us.” – Ronnie Cummins, Organic Consumers Association … “Food Forensics is an essential reality guide to food and water in the 21st century.” – Robert Scott Bell … “Food Forensics is an incredible, ground-breaking book.” – Ty Bollinger, The Truth About Cancer …
Click here to preorder your copy of “Food Forensics” now.
Sources for this article include:
http://www.fda.gov/NewsEvents/PublicHealthFo…
http://www.nutritionaloutlook.com/herbs-bota…
http://www.cannabusiness.com/news/products-i…

Learn more: http://www.naturalnews.com/053369_CBD_hemp_oil_extract_FDA_regulations.html#ixzz43aLcL8Km

A KENTUCKY RESOLUTION to encourage the United States Food and Drug Administration to study the use of medical marijuana


23341971029_4a6753c417_o

On Thursday, February 25, 2016,  HR 173(BR-1583)  was  introduced in House.  This is a Kentucky RESOLUTION to encourage the United States Food and Drug Administration to study the use of medical marijuana.

The Sponsors are David Osborne, Lynn Bechler, and Brad Montell.

This is to encourage the United States Congress to authorize and direct the United States Food and Drug Administration to study the benefits, side effects, drug interactions, and other aspects of medical marijuana.

On Monday, February 29, 2016 it was sent to Health & Welfare (H).

16RS/HR173 (PDF LINK)

UK gets $6 million grant to research cocaine addiction


Saturday, November 21, 2015 

 

Posted: Saturday, November 21, 2015 12:22 AM

By Linda B. Blackford Lexington Herald-Leader

LEXINGTON – A group of University of Kentucky researchers has won a $6 million grant to further develop a potential treatment for cocaine abuse.

UK College of Pharmacy professor Chang-Guo Zhan, along with UK professors Fang Zheng and Sharon Walsh, and Wake Forest University professor Mei-Chuan Ko, are researching new therapies for overdose and addiction.

"Dr. Zhan’s groundbreaking work in this field cannot be overstated," interim dean Kelly M. Smith said. "There currently is no FDA approved treatment for cocaine overdose or cocaine addiction, and Dr. Zhan and his research team are trying to change that. Developing such therapies would be a major breakthrough for health care."

Previously, Zhan’s team designed and tested CocH1, an enzyme that breaks down cocaine in the bloodstream without producing harmful byproducts in the body.

CONTINUE READING…